Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations
N Avril, CA Rose, M Schelling, J Dose… - Journal of clinical …, 2000 - ascopubs.org
PURPOSE: To evaluate the diagnostic value of positron emission tomography (PET) using
fluorine-18 fluorodeoxyglucose (FDG) for the diagnosis of primary breast cancer. PATIENTS …
fluorine-18 fluorodeoxyglucose (FDG) for the diagnosis of primary breast cancer. PATIENTS …
Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose.
N Avril, J Dose, F Jänicke, S Bense, S Ziegler… - Journal of clinical …, 1996 - ascopubs.org
PURPOSE To evaluate the diagnostic value of position emission tomographic (PET)
imaging with F-18 fluorodeoxyglucose (FDG) in differentiating between benign and …
imaging with F-18 fluorodeoxyglucose (FDG) in differentiating between benign and …
Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer
TF Çermik, A Mavi, S Basu, A Alavi - European journal of nuclear medicine …, 2008 - Springer
Purpose The main objective of this study was to determine the efficacy of 18 F-
fluorodeoxyglucose positron emission tomography (FDG PET) to assess the impact of this …
fluorodeoxyglucose positron emission tomography (FDG PET) to assess the impact of this …
Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability
K Scheidhauer, A Scharl, U Pietrzyk, R Wagner… - European journal of …, 1996 - Springer
Positron emission tomography (PET) using fluorine-18 2-deoxy-2-fluoro-d-glucose (FDG) is
of potential value for the diagnosis of malignant tumours. The aim of this study was to …
of potential value for the diagnosis of malignant tumours. The aim of this study was to …
Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer
AR Boerner, M Weckesser, H Herzog, T Schmitz… - European journal of …, 1999 - Springer
Fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) has proven
useful in the differentiation of various tumour entities, including breast cancer. In patients …
useful in the differentiation of various tumour entities, including breast cancer. In patients …
Positron emission tomography and breast masses: comparison with clinical, mammographic, and pathological findings
JP Crowe, LP Adler, RR Shenk, J Sunshine - Annals of Surgical Oncology, 1994 - Springer
Background: Positron emission tomography (PET) is a means of imaging tissue based upon
its metabolic activity. Initial studies in the field of oncology suggest that PET may be useful …
its metabolic activity. Initial studies in the field of oncology suggest that PET may be useful …
Positron emission tomography with fluorine‐18‐deoxyglucose in the detection and staging of breast cancer
OE Nieweg, EE Kim, WH Wong, WF Broussard… - Cancer, 1993 - Wiley Online Library
Background. An increasing number of patients with breast cancer is being treated with
preoperative chemotherapy. Evaluation of treatment response may be facilitated by positron …
preoperative chemotherapy. Evaluation of treatment response may be facilitated by positron …
[HTML][HTML] Comparison between positron emission tomography using 2-[fluorine-18] fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for …
S Mahner, S Schirrmacher, W Brenner, L Jenicke… - Annals of oncology, 2008 - Elsevier
Background The presence, extent and localization of distant metastases are key prognostic
factors in breast cancer patients and play a central role in therapeutic decision making. The …
factors in breast cancer patients and play a central role in therapeutic decision making. The …
Performance of FDG PET/CT in the clinical management of breast cancer
D Groheux, M Espié, S Giacchetti, E Hindié - Radiology, 2013 - pubs.rsna.org
In this analysis, the role of metabolic imaging with fluorine 18 fluorodeoxyglucose (FDG) in
breast cancer is reviewed. The analysis was limited to recent works by using state-of-the-art …
breast cancer is reviewed. The analysis was limited to recent works by using state-of-the-art …
The value of FDG positron emission tomography in the management of patients with breast cancer
L Weir, D Worsley, V Bernstein - The breast journal, 2005 - Wiley Online Library
Increasing experience with positron emission tomography (PET) scanning in breast cancer
patients is revealing a significant role for this imaging modality. This report summarizes the …
patients is revealing a significant role for this imaging modality. This report summarizes the …